Cell-cycle regulator cyclin D1 mRNA and protein overexpression occurs in primary malignant gliomas

International Journal of Oncology

Volumn 9, Issue 3, 1996, Pages 493-497

  Maxwell, Marius ^a,b,c,d   Galanopoulos, Theofanis ^b   Antoniades, Harry N ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

cell cycle; cyclins; glioma; tumorigenesis

Indexed keywords

CYCLINE; MESSENGER RNA;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 0029787440     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.9.3.493     Document Type: Article

References (35)

1. Bishop JM: Molecular themes in oncogenesis. Cell 64: 235-248, 1991.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327-336, 1991.
3. Mikkelsen T, Cairncross JG and Cavenee WK: Genetics of the malignant progression of astrocytoma. J Cell Biochem 46: 3-8, 1991.
4. Yong WH, Chou D and Ueki K: Chromosome 19q deletions overlap telomeric to D19S219 and may target a 425 kb region ccntromeric to D19S112. J Neuropath Exp Neurol 54: 622-626, 1995.
5. von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza RL, Schoenfeld DA, Yasargil MG, Wiestler OD and Seizinger BR: Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77: 295-301, 1992.
6. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Neville-Golden J and Antoniades HN: Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 51: 1345-1351, 1991.
7. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Neville-Golden J, Black P and Antoniades HN: Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86: 131-140, 1990.
8. Maxwell M, Galanopoulos T, Neville-Golden J and Antoniades HN: Overexpression of the ros1 gene in primary human gliomas may contribute to malignant progression. Int J Oncol 8: 713-718, 1996.
9. Louis DN and Seizinger BR: Genetic basis of neurological tumors. Balliere's Clin Neurol 3: 335-352, 1994.
10. Henson JW, Schnitker BL and Correa KM: The retinoblastoma susceptibility (Rb) gene is involved in the malignant progression of human astrocytomas. Ann Neurol 36: 714-721, 1994.
11. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D/cdk4. Nature 366: 704-707, 1993.
12. Ueki K, Rubio M-P and Ramesh V: MTS1/CDKN2 gene mutations are rare in primary human astrocytomas with allelic loss of chromosome 9p. Hum Mol Genet 3: 1841-1845, 1994.
13. Russell DS and Rubinstein LJ: Pathology of Tumors of the Nervous System. 5th ed. E. Arnold, London, Chapter 3, pp219-247, 1989.
14. Miescher T, Whiteside TL and Carrel S: Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors; effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol 136: 1899-1907, 1986.
15. Maxwell M, Galanopoulos T, Neville-Golden J and Antoniades HN: Effect of the expression of transforming factor ß2 in primary human glioblastomas on immunosuppression and loss of immune surveillance. J Neurosurg 76: 799-804, 1992.
16. Antoniades HN, Galanopoulos T, Neville-Golden J and Maxwell M: Expression of insulin-like growth factors I and II and their receptor mRNAs in primary human astrocytomas and meningiomas; in vivo studies using in situ hybridization and immunocytochemistry. Int J Cancer 50: 215-222, 1992.
17. Xiong Y, Connolly T, Futcher B and Beach D: Human D-type cyclin. Cell 65: 691-699, 1991.
18. Jiang JW, Kahn SM, Tomita DF, Zhang Z-F, Lu SH and Weinstein BN: Amplification and expression of the human cyclin D1 gene in esophageal cancer. Cancer Res 52: 2980-2983, 1992.
19. Lammie AC, Fantl V, Smith R, Schuuring E, Brookes S, Michelides R, Dickson C, Arnold A and Peters G: D11S287, a putative oncogene on chromosome 11q13 is amplified and expressed in squamous cell and mammary carcinomas and is linked to BCL-1. Oncogene 6: 439-444, 1991.
20. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B and Bartek J: Abnormal patterns of D-type cyclin expression and G, regulation in human head and neck cancer. Cancer Res 55: 949-956, 1995.
21. Zulch KJ: Histological typing of tumors of the central nervous system. International Histological Classification of Tumors. No. 21. Geneva, World Health Organization, 1979.
22. Ponte P, Ng NY and Engel T: Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human ß-actin cDNA. Nucleic Acid Res 12: 1687-1696, 1984.
23. Lewis RA, Balcanck K and Krek V: Sequences of a cDNA encoding mouse glial fibrillary acidic protein: structural conservation of intermediate filaments. Proc Natl Acad Sci USA 81: 2743-2746, 1984.
24. Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI and Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70: 993-1006, 1992.
25. Li Y, Nichols MA, Shay RW and Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p116 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082, 1994.
26. Lukas J, Pagano R, Staskova W, Draetta G and Bartek J: Cyclin Dl protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 9: 707-718, 1994.
27. Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev 7: 812-821, 1993.
28. Quelle DE, Ashmun RA, Shurtleff SA, Kate J-Y, Bar-Sag U, Rouse MF and Sherr CJ: Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7: 1559-1571, 1993.
29. Weinstat-Saslow TG, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel RF, Simpson JF, Page DL and Steeg FD: Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med 1: 1-4, 1995.
30. Xiong Y, Zhang H and Beach D: D-type cyclins associated with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514, 1992.
31. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT and Jacks T: Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet 7: 480-484, 1994.
32. Sherr CJ: Mammalian G1 cyclins. Cell 73: 1059-1065, 1993.
33. Lebwohl DE, Muise-Helmericks R, Sepp-Lorenzino T, Serve S, Timaul M, Bol R, Borgen P and Rosen M: A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. Oncogene 9: 1925-1929, 1994.
34. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE and Skolnick NH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440, 1994.
35. Nobori F, Miura Y, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin-dependent kinase 4-inhibitor gene in multiple human cancers. Nature 368: 753-756, 1994.